Trial results of a drug appearing to slow Alzheimer's disease represent a "historic moment", experts say.works when given in the early stages of the disease.And even the limited data has generated excitement among dementia scientists and charities.The drug, lecanemab, is designed to remove clumps of toxic beta-amyloid proteins that build up in the brains of people with Alzheimer's disease.
In this trial, 1,795 volunteers in the early stages of Alzheimer's disease were injected with lecanemab every two weeks and regularly had their memory and mental agility tested. The companies are now applying for regulatory approval for the drug to be given in the US, Europe and Japan. Prof John Hardy, from University College London, said the results were "truly encouraging" and "look like the first truly positive mechanistic trial results in Alzheimer's disease"."This is clearly not a magic bullet but it looks like a definite 'end of the beginning'."But its US launch was widely criticised and the EU refused to allow it over doubts about whether it worked.
My dad has been diagnosed with Alzheimer since 2015, my mum found out about Sacha inchi’s oil slowing down Alzheimer, so he began to take it since 2017, just now after contracting Covid 19 ppl start to notice his illness bcos his lack of oxigent levels went down to 65% with covid
I forgot to take mine.
Don't give it to anti-vaxxers they know best..
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WSJhealth - 🏆 413. / 53 Read more »
Source: YahooNews - 🏆 380. / 59 Read more »
Source: cnni - 🏆 326. / 59 Read more »
Source: USATODAY - 🏆 100. / 63 Read more »